Biomarin Pharmaceutical (BMRN) Common Equity (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Common Equity of $6.32 billion for Q2 2026, up 4.9% from $6.03 billion a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical's Common Equity came in at $6.09 billion, up 7.6% from FY2024.
- Annual Common Equity has increased for 16 consecutive years, with a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
- In prior years, Biomarin Pharmaceutical's Common Equity was $5.66 billion in FY2024 (+14.3%), $4.95 billion in FY2023 (+7.6%), $4.6 billion in FY2022 (+7.9%) and $4.27 billion in FY2021 (+4.0%).
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2009.
- On a year-over-year basis, Common Equity has increased in each of the last 40 quarters, with growth averaging 10.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Common Equity ranged from 4.0% (Q4 2021) to 14.3% (Q4 2024).
- According to Business Quant data, Common Equity for the three prior quarters was $6.21 billion (Q1 2026), $6.09 billion (Q4 2025) and $6.06 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 6.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Bn |
| Mar 31, 2026 | 6.21 Bn |
| Dec 31, 2025 | 6.09 Bn |
| Sep 30, 2025 | 6.06 Bn |
| Jun 30, 2025 | 6.03 Bn |
| Mar 31, 2025 | 5.79 Bn |
| Dec 31, 2024 | 5.66 Bn |
| Sep 30, 2024 | 5.41 Bn |
| Jun 30, 2024 | 5.29 Bn |
| Mar 31, 2024 | 5.07 Bn |
| Dec 31, 2023 | 4.95 Bn |
| Sep 30, 2023 | 4.90 Bn |
| Jun 30, 2023 | 4.78 Bn |
| Mar 31, 2023 | 4.66 Bn |
| Dec 31, 2022 | 4.60 Bn |
| Sep 30, 2022 | 4.57 Bn |
| Jun 30, 2022 | 4.50 Bn |
| Mar 31, 2022 | 4.39 Bn |
| Dec 31, 2021 | 4.27 Bn |
| Sep 30, 2021 | 4.26 Bn |
API Access
Biomarin Pharmaceutical Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();